Chief Financial and Operating Officer — Robert Lutz: Robert Lutz was promoted to Chief Financial and Operating Officer, succeeding David Lowrance who resigned due to health reasons.

Entry into a Material Definitive Agreement. On March 10, 2026, Savara Inc. (the “Company”) entered into an Agreement of Lease (the “Lease”) with ML7 Yardley Partners, LP (“Landlord”), pursuant to which the Company will lease approximately 10,795 square feet of office space located at 19 W. College Avenue, Suite 200, Yardley, PA 19067. The Company plans to relocate its headquarters to this location. The term of the Lease commences on July 1, 2026 and continues until December 1, 2031 (the “Term…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01, “Entry into a Material Definitive Agreement,” is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 27, 2026 SAVARA INC. a Delaware corporation By:…

Entry into a Material Definitive Agreement. On January 26, 2026, Savara Inc. (the “Company”) entered into a First Amendment (the “First Amendment”) to the Loan and Security Agreement, dated March 26, 2025 (the “Loan Agreement”), with the lenders party thereto (the “Lenders”) and Hercules Capital, Inc., as administrative agent and collateral agent. As amended, the Loan Agreement provides for the Company to borrow up to an aggregate of $105 million of term loans. The First Amendment reset the t…

Entry into a Material Definitive Agreement. On October 29, 2025, Savara Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell (i) an aggregate of 23,809,524 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and (ii) pre-funded…

Other Events. Corporate Presentation An abbreviated version of the Company’s corporate presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference herein. The Company undertakes no duty or obligation to update or revise the information contained in this presentation, although it may do so from time to time. Any such updates may be made through the Investor Relations page of the Company’s website, the filing of other reports or documents with the SEC,…

Entry into a Material Definitive Agreement. On October 29, 2025, Savara Inc. (the “Company”) announced its entry into a purchase and sale agreement (the “Purchase Agreement”) with funds managed by RTW Investments, LP (the “Purchaser”). Under the terms of the Purchase Agreement, the Purchaser has agreed to pay the Company $75 million (the “Purchase Price”) upon approval of the Company’s investigational inhaled biologic, molgramostim inhalation solution (“MOLBREEVI”), for the treatment of autoi…

Termination of Material Definitive Agreement. As previously disclosed, on July 6, 2021, Savara Inc. (the “Company”) entered into a Sales Agreement with Evercore Group L.L.C. (“Evercore”), as sales agent (the “ATM Agreement”), pursuant to which the Company may offer and sell up to an aggregate of $100.0 million of shares of its common stock, par value $0.001 per share, from time to time through Evercore in “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as am…

Termination of a Material Definitive Agreement. In connection with the initial draw under the Loan Agreement on March 26, 2025 and the use of proceeds for the full repayment of the Company’s obligations thereunder, the Company terminated that certain Amended and Restated Loan and Security Agreement, dated April 21, 2022, between the Registrant and its subsidiary, Aravas Inc., as borrowers, and Silicon Valley Bank.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01, “Entry into a Material Definitive Agreement,” is incorporated herein by reference.

Entry into a Material Definitive Agreement. On March 26, 2025 (the “Closing Date”), Savara Inc. (the “Company”) announced that it had entered into a Loan and Security Agreement (the “Loan Agreement”) with the lenders party thereto (the “Lenders”) and Hercules Capital, Inc., as administrative agent and collateral agent (the “Agent”). The Loan Agreement provides for the Company to borrow up to $200 million of term loans (the “Term Loan”) that may be advanced in multiple tranches. The initial ad…

The filing details the target bonus amounts for executive officers, which is a routine compensation matter.

Entry into a Material Definitive Agreement. On June 27, 2024, Savara Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of 26,246,720 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) to the Underwriters in an u…

Director — Dr. Ricky Sun: Dr. Sun decided not to stand for reelection to the Board following his current term.

Entry into a Material Definitive Agreement. The information included in

Entry into a Material Definitive Agreement On February 13, 2024, Savara Inc. (the “Company”) entered into a Master Services Agreement (the “Agreement”) with Fujifilm Diosynth Biotechnologies UK Limited, Fujifilm Diosynth Biotechnologies Texas, LLC, and Fujifilm Diosynth Biotechnologies U.S.A., Inc. (collectively, “Fujifilm”), pursuant to which Fujifilm will continue to provide development and manufacturing services related to active pharmaceutical ingredient for the Company’s molgramostim pro…

The filing details the target bonus amounts for executive officers, which is a routine compensation matter.

Entry into a Material Definitive Agreement. On July 12, 2023, Savara Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell (i) an aggregate of 21,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) pre-funded wa…

Entry into a Material Definitive Agreement. On February 28, 2023, Savara Inc. (“Savara”) entered into an amendment (the “Amendment”) to the Agreement of Lease, dated July 7, 2021, between Savara and 1717 OSSRE, LLC (the “Lease”) in order to increase the size of Savara’s offices in Langhorne, PA. Savara plans to relocate its headquarters to this location. Pursuant to the Lease, Savara currently leases 2,465 square feet of office space on the third floor of the building located at 1717 Langhorn…

Chief Operating Officer — Robert Lutz: Savara hired Robert Lutz as its Chief Operating Officer.

Chief Financial & Administrative Officer — Dave Lowrance: Dave Lowrance was promoted to Chief Financial & Administrative Officer and entered into an amended employment agreement.

Chief Medical Officer — Dr. Badrul Chowdhury: Dr. Chowdhury resigned as Chief Medical Officer.